small_state_seal
VIG_home_link _spacer sec_state_link elections_link pol_reform_link audio_cassette_link vig_feedback
_propositions  
Title and Summary
prop73_link
prop74_link
prop75_link
prop76_link
prop77_link
prop78_link
prop79_link
prop80_link
ballot_measure_summary_link
voter_billrights_link
pdf_download_link
  OFFICIAL TITLE AND SUMMARY
Prepared by the Attorney General
_spacer

PROPOSITION 78

DISCOUNTS ON PRESCRIPTION DRUGS. INITIATIVE STATUTE.

  • Establishes discount prescription drug program, overseen by California Department of Health Services.
  • Enables certain low- and moderate-income California residents to purchase prescription drugs at reduced prices.
  • Authorizes Department: to contract with participating pharmacies to sell prescription drugs at agreed-upon discounts negotiated in advance; to negotiate rebate agreements with participating drug manufacturers.
  • Imposes $15 annual application fee.
  • Creates state fund for deposit of drug manufacturers’ rebate payments.
  • Requires Department’s prompt determination of residents’ eligibility, based on listed qualifications.
  • Permits outreach programs to increase public awareness.
  • Allows program to be terminated under specified conditions.

SUMMARY OF LEGISLATIVE ANALYST'S ESTIMATE OF NET STATE AND LOCAL GOVERNMENT FISCAL IMPACT:

  • One-time and ongoing state costs, potentially in the millions to low tens of millions of dollars annually, for administration and outreach activities for a new drug discount program. A significant share of these costs would probably be borne by the state General Fund.
  • State costs, potentially in the low tens of millions of dollars, to cover the funding gap between when drug rebates are collected by the state and when the state pays funds to pharmacies for drug discounts provided to consumers. Any such costs not covered through advance rebate payments from drug makers would be borne by the state General Fund.
  • Unknown potentially significant savings for state and county health programs due to the availability of drug discounts.
  • Potential unknown effects on state revenues and expenditures from changes in prices and quantities of drugs sold in California.

 

Back to the Top